Table 2 |
|
| Benefits of drug load in liposomes | |
| Benefits of drug load in liposome | Examples |
| 1. Improved solubility of lipophilic and amphiphilic drugs | Amphotericin B, porphyrins, minoxidil, some peptides, and anthracyclines, respectively; hydrophilic drugs, such as anticancer agent doxorubicin or acyclovir |
| 2. Passive targeting to the cells of the immune system, especially cells of the mononuclear phagocytic system | Antimonials, amphotericin B, porphyrins, vaccines, immunomodulators |
| 3. Sustained release system of systemically or locally administered liposomes | Doxorubicin, cytosine arabinoside, cortisones, biological proteins or peptides such as vasopressin |
| 4. Site-avoidance mechanism | Doxorubicin andamphotericin B |
| 5. Site-specific targeting | Anti-inflammatory drugs, anti-cancer, anti-infection |
| 6. Improved transfer of hydrophilic, charged molecules | Antibiotics, chelators, plasmids, and genes |
| 7. Improved penetration into tissues | Corticosteroids, anesthetics, and insulin |
Akbarzadeh et al. Nanoscale Research Letters 2013 8:102 doi:10.1186/1556-276X-8-102